Lipid biosignature of breast cancer tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424 Koek MM, Jellema RH, van der Greef J et al (2011) Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics 7:307–328 Jelonek K, Ros M, Pietrowska M, Widlak P (2013) Cancer biomarkers and mass spectrometry-based analyses of phospholipids in body fluids. Clin Lipidol 8:137–150 Cho YT, Su H, Chiang YY et al (2017) Fine needle aspiration combined with matrix-assisted laser desorption ionization time-of-flight/mass spectrometry to characterize lipid biomarkers for diagnosing accuracy of breast cancer. Clin Breast Cancer 17:373–381.e1 Cho YT, Su H, Huang TL et al (2013) Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis. Clin Chim Acta 415:266–275 Islam SR, Manna SK (2019) Lipidomic analysis of cancer cell and tumor tissues. Methods Mol Biol 1928:175–204 Long J, Zhang C-J, Zhu N et al (2018) Lipid metabolism and carcinogenesis, cancer development. Am J Cancer Res 8:778–791 Fahy E, Cotter D, Sud M, Subramaniam S (2011) Lipid classification, structures and tools. Biochim Biophys Acta 1811:637–647 Kim IC, Lee JH, Bang G et al (2013) Lipid profiles for HER2-positive breast cancer. Anticancer Res 33:2467–2472 Fuchs B, Schiller J (2008) MALDI-TOF MS analysis of lipids from cells, tissues and body fluids. Subcell Biochem 49:541–565 Du Y, Wang Q, Zhang X et al (2017) Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. J Exp Clin Cancer Res 36:66 Abdelzaher E, Mostafa MF (2015) Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence. Tumor Biol 36:5473–5483 Uehara T, Kikuchi H, Miyazaki S et al (2016) Overexpression of lysophosphatidylcholine acyltransferase 1 and concomitant lipid alterations in gastric cancer. Ann Surg Oncol 23:206–213 Chen H-Z, Qu Y-H, Diao C-Y et al (2016) Expression of phospholipase A2 in breast cancer tissues and its significance. Int J Clin Exp Pathol 9(11):11820–11825 Yamashita SI, Yamashita JI, Ogawa M (1994) Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer 69:1166–1170 Kang HS, Lee SC, Park YS et al (2011) Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype. BMC Cancer 11:465 Kim KJ, Kim HJ, Park HG et al (2016) A MALDI-MS-based quantitative analytical method for endogenous estrone in human breast cancer cells. Sci Rep 6:1–7 Phillips L, Gill AJ, Baxter RC (2019) Novel prognostic markers in triple-negative breast cancer discovered by MALDI-mass spectrometry imaging. Front Oncol 9:379 Schiller J, Süß R, Arnhold J et al (2004) Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res 43:449–488 Leopold J, Popkova Y, Engel K, Schiller J (2018) Recent developments of useful MALDI matrices for the mass spectrometric characterization of lipids. Biomolecules 8:173 Fuchs B, Bischoff A, Sü R et al (2009) Phosphatidylcholines and -ethanolamines can be easily mistaken in phospholipid mixtures: a negative ion MALDI-TOF MS study with 9-aminoacridine as matrix and egg yolk as selected example. Anal Bioanal Chem 395:2479–2487 Sevinsky CJ, Khan F, Kokabee L et al (2018) NDRG1 regulates neutral lipid metabolism in breast cancer cells. Breast Cancer Res 20:55 Law S-H, Chan M-L, Marathe GK et al (2019) An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci 20:1149 Hao W, Friedman A (2014) The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. PLoS ONE 9:e90497 Punnonen K, Hietanen E, Auvinen O, Punnonen R (1989) Phospholipids and fatty acids in breast cancer tissue. J Cancer Res Clin Oncol 115:575–578 Goto T, Terada N, Inoue T et al (2014) The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. PLoS ONE 9:e90242 Sparvero LJ, Amoscato AA, Dixon CE et al (2012) Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem Phys Lipids 165:545–562 Harvey DJ (1996) Matrix-assisted laser desorption/ionisation mass spectrometry of oligosaccharides and glycoconjugates. J Chromatogr A 720:429–446 Petković M, Schiller J, Müller M et al (2001) Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal Biochem 289:202–216 Fuchs B, Süß R, Schiller J (2010) An update of MALDI-TOF mass spectrometry in lipid research. Prog Lipid Res 49:450–475 Petković M, Vocks A, Müller M et al (2005) Comparison of different procedures for the lipid extraction from HL-60 cells: A MALDI-TOF mass spectrometric study. Zeitschrift fur Naturforsch-Sect C J Biosci 60:143–151 Teuber K, Riemer T, Schiller J (2010) Thin-layer chromatography combined with MALDI-TOF-MS and 31P-NMR to study possible selective bindings of phospholipids to silica gel. Anal Bioanal Chem 398:2833–2842 Schiller J, Süß R, Fuchs B et al (2007) The suitability of different DHB isomers as matrices for the MALDI-TOF MS analysis of phospholipids: Which isomer for what purpose? Eur Biophys J 36:517–527 Schiller J, Süß R, Petković M, Arnold K (2002) Thermal stressing of unsaturated vegetable oils: Effects analysed by MALDI-TOF mass spectrometry,1H and31P NMR spectroscopy. Eur Food Res Technol 215:282–286 Schiller J, Arnhold J, Benard S et al (1999) Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: a methodological approach. Anal Biochem 267:46–56 Angelini R, Vortmeier G, Corcelli A, Fuchs B (2014) A fast method for the determination of the PC/LPC ratio in intact serum by MALDI-TOF MS: An easy-to-follow lipid biomarker of inflammation. Chem Phys Lipids 183:169–175 Miletić Vukajlović J, Drakulić D, Pejić S et al (2019) Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson’s disease. Rapid Commun Mass Spectrom 34:8595 Kamčeva T, Radisavljevic̈ M, Vukic̈evic̈ I, et al (2013) Interactions of platinum and ruthenium coordination complexes with pancreatic phospholipase A 2 and phospholipids investigated by MALDI TOF mass spectrometry. Chem Biodivers 10:1972–1986 Petković M, Müller J, Müller M et al (2002) Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for monitoring the digestion of phosphatidylcholine by pancreatic phospholipase A2. Anal Biochem 308:61–70 Kim Y, Shanta SR, Zhou LH, Kim KP (2010) Mass spectrometry based cellular phosphoinositides profiling and phospholipid analysis: A brief review. Exp Mol Med 42:1–11 Margaria JP, Ratto E, Gozzelino L et al (2019) Class II PI3Ks at the intersection between signal transduction and membrane trafficking. Biomolecules 9:104 Dogliotti G, Kullmann L, Dhumale P et al (2017) Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression. Nat Commun 8:1–2 Müller M, Schiller J, Petković M et al (2001) Limits for the detection of (poly-)phosphoinositides by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS). Chem Phys Lipids 110:151–164 Milne SB, Ivanova PT, DeCamp D et al (2005) A targeted mass spectrometric analysis of phosphatidylinositol phosphate species. J Lipid Res 46:1796–1802